IDiyas

For the Inventor, By the Inventor

Newark, DE, United States of America

Joseph M Fortunak

USPTO Granted Patents = 12

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Newark, DE (US) (2000 - 2002)
  • Hawthorn Woods, IL (US) (2003)

Company Filing History:

goldMedal7 out of 106 
 
Dupont Pharmaceuticals Company
 patents
silverMedal2 out of 234 
 
Bristol-myers Squibb Pharma Company
 patents
bronzeMedal1 out of 10 
 
Bristol-myers Squibb Pharma Corporation
 patents
4. 1 out of 15 
 
Dupont Pharmaceuticals, Inc.
 patents
5. 1 out of 832,680 
Other
 patents

Years Active: 2000-2003

Loading Chart...
12 patents (USPTO):Explore Patents
1. 6555686 - Asymmetric synthesis of quinazolin-2-ones useful as HIV reverse transcriptase inhibitors (2003-04-29),
2. 6492515 - 4,4-disubstituted-1, 4-dihydro-2H-3, 1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same (2002-12-10),
3. 6452000 - Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate (2002-09-17),
4. 6359164 - Process for the preparation of cyclopropylacetylene (2002-03-19),
5. 6303780 - 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same (2001-10-16),
6. 6297410 - Process for the preparation of cyclopropylacetylene (2001-10-02),
7. 6288297 - Process for the preparation of cyclopropylacetylene (2001-09-11),
8. 6218534 - Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate (2001-04-17),
9. 6214847 - Crystalline 10,10-Bis((2-fluoro-4-pyridinyl)methyl)-9(10H)-Anthracenone and an improved process for preparing the same (2001-04-10),
10. 6194569 - Efficient process for the preparation of [S-(R,S)]-N-[1,3-benzodioxol-5-yl)butyl]-3,3-diethyl-2[4-[4-methyl-1-piperazinyl)carbonyl]phenoxy]-4-oxo-1-azetidine carboxamide, a human leukocyte elastase inhibitor (2001-02-27),
11. 6140499 - 4,4-disubstituted-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV (2000-10-31),
12. 6049019 - Process for the preparation of cyclopropylacetylene (2000-04-11),

Title: The Innovations of Joseph M. Fortunak

Introduction

Joseph M. Fortunak is a prominent inventor based in Newark, Delaware, known for his significant contributions to the field of pharmaceuticals. With a total of 12 patents to his name, Fortunak has made remarkable strides in developing compounds that are crucial for medical advancements, particularly in the fight against HIV.

Latest Patents

One of his latest patents involves the asymmetric synthesis of quinazolin-2-ones, which are useful as HIV reverse transcriptase inhibitors. This invention focuses on the chiral ligand-mediated addition of cyclopropylacetylide, showcasing innovative methods to create effective inhibitors. Another notable patent is for 4,4-disubstituted-1,4-dihydro-2H-3,1-benzoxazin-2-ones, which also serve as HIV reverse transcriptase inhibitors and detail the intermediates and processes for their production.

Career Highlights

Throughout his career, Fortunak has worked with leading pharmaceutical companies, including DuPont Pharmaceuticals Company and Bristol-Myers Squibb Pharma Company. His work in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to the development of life-saving medications.

Collaborations

Fortunak has collaborated with notable colleagues such as Zhe Wang and Jianguo Yin, further enhancing the impact of his research and inventions in the pharmaceutical industry.

Conclusion

Joseph M. Fortunak's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator in the fight against HIV. His work continues to inspire advancements in medical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…